Momentum Pharma Ltd has been honoured with a Queen’s Award for Enterprise for excellence in International Trade.
Announced today Thursday 21 April 2022, Momentum Pharma has been recognised for its excellence in International Trade. Momentum Pharma is one of 225 organisations nationally to be recognised with a prestigious Queen’s Award for Enterprise.
Momentum Pharma was set up in 2013 and has since become a trusted Clinical Resource Organisation for Biotech and Pharmaceutical companies and other larger CROs.
Employing a small but growing core team from its UK headquarters in Hereford, together with a global consultant team of over 1,000 people, they are proud to provide the support of a virtual Clinical Research Organisation to the vital life enhancing and life saving work that Biotech, Pharmaceutical companies and CROs of all sizes undertake.
Melissa Melton, Momentum Pharma CEO said, “I can’t express enough how privileged we are to win this most prestigious award and it is with absolute gratitude for everyone we work with around the world; our Clients/Sponsors, Consultants, team and family. We thank them all for their continuous support of Momentum Pharma and the work we do to support the global clinical trials that go on to enhance and save lives.”
Jon Melton, Momentum Pharma COO adds, “It’s truly humbling to received this award. This award is recognition of the work everyone at Momentum Pharma does in striving for excellence in the delivery of our services to make a difference to everyone’s lives. We’re excited to be part of this special community of award winners, and congratulate all the businesses honoured today.
Now in its 56th year, the Queen’s Awards for Enterprise are the most prestigious
business awards in the country, with winning businesses able to use the esteemed
Queen’s Awards Emblem for the next five years. Applications for Queen’s Awards for Enterprise 2023 open on the 1st May 2022. For more information, visit https://www.gov.uk/queens-awards-for-enterprise